ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹18 Cr | ₹-19 Cr | ₹18 Cr | ₹-11 Cr | ₹-74 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ORCHID PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹-11 Cr |
| Mar2021 | ₹-74 Cr |
How is Net Cash Inflow / Outflow of ORCHID PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹18 Cr | Positive | |
| Mar2022 | ₹-11 Cr | Negative | |
| Mar2021 | ₹-74 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹4,933.1 Cr | -1.3% | 23.3% | 39.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -1.3% |
23.3% |
39.5% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses